Table 4.
Common terminology criteria for adverse event (CTCAE) adverse events of transarterial chemoembolization (n = 66)
| Abdominal pain | 51 (77.3%) |
| Grade 1 | 23 (34.8%) |
| Grade 2 | 15 (22.3) |
| Grade 3 | 13 (19.7%) |
| Nausea | 19 (28.8%) |
| Grade 1 | 19 (28.8%) |
| Grade 2 | 0 (0%) |
| Grade 3 | 0 (0%) |
| Vomiting | 14 (21.2%) |
| Grade 1 | 14 (21.2%) |
| Grade 2 | 0 (0%) |
| Grade 3 | 0 (0%) |
| Fever | 15 (22.3%) |
| Grade 1 | 14 (21.2%) |
| Grade 2 | 1 (1.5%) |
| Grade 3 | 0 (0%) |
| Alanine aminotransferase increased | 50 (75.8%) |
| Grade 1 | 33 (50.0%) |
| Grade 2 | 9 (13.6%) |
| Grade 3 | 8 (12.1%) |
| Aspartate aminotransferase increased | 63 (95.5%) |
| Grade 1 | 21 (31.8%) |
| Grade 2 | 20 (30.3%) |
| Grade 3 | 22 (33.3%) |
| Anemia | 33 (50%) |
| Grade 1 | 20 (30.3%) |
| Grade 2 | 11 (16.7%) |
| Grade 3 | 2 (3.0%) |
| Neutropenia | 0 (0%) |
| Intra-abdominal infection | 4 (6.1%) |
| Grade 1 | 0 (0%) |
| Grade 2 | 0 (0%) |
| Grade 3 | 4 (6.1%) |
| Cholecystitis | 0 (0%) |